The recall of HiPP baby food products over suspected rodenticide contamination is putting significant pressure on the management and reputation... Read more
Tag: #Global Trends
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
At the American Association for Cancer Research (AACR) Annual Meeting 2026, Abbott presented new data demonstrating significant advancements in its... Read more
SK Life Science Labs to present new preclinical data on targeted protein degradation at AACR 2026
At the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, SK Life Science Labs, a subsidiary... Read more
MSN Laboratories launches Semabest Semaglutide in India to enhance affordability
MSN Laboratories has officially introduced Semabest, its domestic semaglutide brand, to the Indian market following approval from the Central Drugs... Read more
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Partner to Advance ADC Manufacturing
Piramal Pharma Solutions (India) and Ajinomoto Bio-Pharma Services (Japan) have announced a strategic collaboration to enhance the development and manufacturing... Read more
European Commission approves Merck’s ENFLONSIA™ (clesrovimab) for infant RSV prevention
The European Commission (EC) has officially granted marketing authorization for ENFLONSIA™ (clesrovimab), a long-acting monoclonal antibody developed by Merck (MSD)... Read more
Bayer’s FXIa inhibitor asundexian reduces ischemic stroke risk without increasing major bleeding
Bayer has announced the publication of full results from the Phase III OCEANIC-STROKE study in The New England Journal of... Read more
Terremoto secures $108M in Series C to advance next-generation AKT inhibitor programs
Terremoto Biosciences has successfully closed a $108 million Series C financing round. The capital will be utilized to push its... Read more
Roche to launch new trial for Elevidys following European regulatory setback
Swiss drugmaker Roche has announced plans to initiate a new global Phase 3 clinical trial for Elevidys. This move is... Read more









